Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Brandwein

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Current Hematologic Malignancy Reports|March 1, 2017
New Treatment Strategies for Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaLalit Saini, Joseph Brandwein
Leukemia Research Reports|September 6, 2024
Successful treatment of AML using non-intensive chemotherapy in Jehovah's Witness patientsDavid Page, Daniel Sawler, Joseph Brandwein
Leukemia Research|March 25, 2026
Impact of measurable residual disease on outcomes using a modified DFCI protocol for adults with BCR-ABL negative acute lymphoblastic leukemiaJoseph Brandwein, Artur Szkotak, David Page, et al.
Archives of Pathology & Laboratory Medicine|March 2, 2005
Hairy cell leukemia variant with features of intrasinusoidal bone marrow involvementCharin Ya-In, Joseph Brandwein, Dominic Pantalony, et al.
Leukemia Research|July 14, 2006
CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotypeHong Chang, Joanna Yeung, Joseph Brandwein, et al.
Leukemia & Lymphoma|May 26, 2017
Persistent cytogenetic abnormalities in patients undergoing intensive chemotherapy for acute myeloid leukemiaLalit Saini, Joseph Brandwein, Artur Szkotak, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 22, 2025
Proposed Modifications to Prognostic Classification of AML Patients Treated With Intensive Chemotherapy Based on Recent Real-World DataJoseph Brandwein, David Page, Elena Liew, et al.
Human Pathology|September 4, 2012
Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotypeHarry Dang, Allan Jiang, Suzanne Kamel-Reid, et al.
Leukemia Research|August 6, 2010
Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutationAllan Jiang, Hua Jiang, Joseph Brandwein, et al.
Leukemia Research|August 11, 2007
The morphological subcategories of acute monocytic leukemia (M5a and M5b) share similar immunophenotypic and cytogenetic features and clinical outcomesPierre Villeneuve, Dae Tong Kim, Wei Xu, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Current Hematologic Malignancy Reports|March 1, 2017
New Treatment Strategies for Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaLalit Saini, Joseph Brandwein
Leukemia Research Reports|September 6, 2024
Successful treatment of AML using non-intensive chemotherapy in Jehovah's Witness patientsDavid Page, Daniel Sawler, Joseph Brandwein
Leukemia Research|March 25, 2026
Impact of measurable residual disease on outcomes using a modified DFCI protocol for adults with BCR-ABL negative acute lymphoblastic leukemiaJoseph Brandwein, Artur Szkotak, David Page, et al.
Archives of Pathology & Laboratory Medicine|March 2, 2005
Hairy cell leukemia variant with features of intrasinusoidal bone marrow involvementCharin Ya-In, Joseph Brandwein, Dominic Pantalony, et al.
Leukemia Research|July 14, 2006
CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotypeHong Chang, Joanna Yeung, Joseph Brandwein, et al.
Leukemia & Lymphoma|May 26, 2017
Persistent cytogenetic abnormalities in patients undergoing intensive chemotherapy for acute myeloid leukemiaLalit Saini, Joseph Brandwein, Artur Szkotak, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 22, 2025
Proposed Modifications to Prognostic Classification of AML Patients Treated With Intensive Chemotherapy Based on Recent Real-World DataJoseph Brandwein, David Page, Elena Liew, et al.
Human Pathology|September 4, 2012
Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotypeHarry Dang, Allan Jiang, Suzanne Kamel-Reid, et al.
Leukemia Research|August 6, 2010
Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutationAllan Jiang, Hua Jiang, Joseph Brandwein, et al.
Leukemia Research|August 11, 2007
The morphological subcategories of acute monocytic leukemia (M5a and M5b) share similar immunophenotypic and cytogenetic features and clinical outcomesPierre Villeneuve, Dae Tong Kim, Wei Xu, et al.
Pageof 8